Correlation Between Opthea and Pardes Biosciences

Can any of the company-specific risk be diversified away by investing in both Opthea and Pardes Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opthea and Pardes Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Opthea and Pardes Biosciences, you can compare the effects of market volatilities on Opthea and Pardes Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opthea with a short position of Pardes Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opthea and Pardes Biosciences.

Diversification Opportunities for Opthea and Pardes Biosciences

0.11

Correlation Coefficient

Opthea  Pardes Biosciences

Average diversification

The 3 months correlation between Opthea and Pardes is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Opthea and Pardes Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pardes Biosciences and Opthea is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opthea are associated (or correlated) with Pardes Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pardes Biosciences has no effect on the direction of Opthea i.e., Opthea and Pardes Biosciences go up and down completely randomly.

Pair Corralation between Opthea and Pardes Biosciences

Considering the 90-day investment horizon Opthea is expected to generate 34.42 times less return on investment than Pardes Biosciences. But when comparing it to its historical volatility, Opthea is 1.16 times less risky than Pardes Biosciences. It trades about 0.0 of its potential returns per unit of risk. Pardes Biosciences is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  153.00  in Pardes Biosciences on September 13, 2024 and sell it today you would earn a total of  61.00  from holding Pardes Biosciences or generate 39.87% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	29.96%
Values	Daily Returns

Opthea  vs.  Pardes Biosciences

Opthea

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Opthea are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Opthea may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pardes Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pardes Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Pardes Biosciences is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Opthea and Pardes Biosciences

The main advantage of trading using opposite Opthea and Pardes Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opthea position performs unexpectedly, Pardes Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pardes Biosciences will offset losses from the drop in Pardes Biosciences' long position.

The idea behind Opthea and Pardes Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.